1.
Predictive model of systemic chemotherapy risks in pancreatic cancer patients with distant metastasis
伴远处转移胰腺癌患者化疗风险预测模型研究
2.
The design of the therapy project must consider the benefit and the risk bring with chemical therapy.
治疗方案的设计要权衡化疗获益和风险,采取个体化治疗。
3.
Study on Risk of Market Orientation of Health Service and the Risk Control Mechanism;
我国医疗服务市场化风险及其治理机制研究
4.
Application of information construction to medical risk management in a hospital
医院信息化建设在医疗风险管理中应用的研究
5.
Multi-factor Analysis of the Risk of the Nonoperative Treatment of Upper Digestive Tract Perforation
非手术治疗上消化道穿孔的风险多因素分析
6.
The nursing risks management of insulin pump intensive treatment in diabetes
应用胰岛素泵强化治疗糖尿病的护理风险管理
7.
Study on the operational risk of new adjuvant chemotherapy in treating advanced gastric cancer
新辅助化疗对进展期胃癌手术风险的研究
8.
Optimization design for ventilation pipeline of emergent diagnosis and treatment ward
危险传染病应急诊疗病房通风管道的优化设计
9.
Especially it analyses changes: the stockpile risk into the arrear risk, operation risk changes market risk, and credit risk into finance risk.
特别是库存风险转化为挂帐风险，经营风险转化为市场波动风险，信贷风险转化为财政风险等；
10.
The risk of physician-establishment the insurance system of medical post
医师的风险——医疗职务保险制度的建立
11.
The Moral Hazard and Guard in the Social Medical Insurance of Our Country;
我国社会医疗保险中的道德风险管理
12.
The Research on the Moral Hazard Control of Commercial Medical Insurance;
商业医疗保险中的道德风险控制研究
13.
The risk and avoidance of medical insurance system in urban and town residents;
城镇居民医疗保险制度的风险及规避
14.
Moral hazard in the fundamental health insurance and controls;
基本医疗保险中的道德风险及其控制
15.
Study on the Risk Management Problem of Social Medical Insurance Fund in China;
我国社会医疗保险基金风险管理问题
16.
The Research on the Moral Hazard Control of Commercial Medical Insurance in China
我国商业医疗保险道德风险控制研究
17.
The Moral Hazard in the Society Medical Insurance and the Way to Control
社会医疗保险中的道德风险及其控制
18.
Although there are risks with gene therapy, Thrasher believes it is safer than conventional bone marrow transplants which often involve chemotherapy.
虽然基因治疗有风险，思拉舍还是认为基因治疗比常需配合化学疗法的常规骨髓移植更加安全。